AlvotechAlvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies Healthcare Conference in New York on June 7, 2023. Alvotech will present and host investor and business meetings at the conference. Anil Okay, Chief Commercial Officer is scheduled to give a presentation on June 7, 2023 at 4:30 pm EST. Except as specifically set forth therein, Alvotech disclaims responsibility for the content of periodic filings, disclosures and other reports made available by its partners. None of the information on the Alvotech website shall be deemed part of this press release.

Source: The North Africa Journal May 31, 2023 11:30 UTC